🇺🇸 FDA
Patent

US 8802836

Cloning and recombinant productions of Vespula venom protease and methods of use thereof

granted A61KA61K39/35A61P

Quick answer

US patent 8802836 (Cloning and recombinant productions of Vespula venom protease and methods of use thereof) held by PLS-Design GmbH expires Mon Aug 07 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
PLS-Design GmbH
Grant date
Tue Aug 12 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 07 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K39/35, A61P, A61P37/08